CClinicalTrials.gg
RecruitingNCT06781749Updated May 11, 2026

New Approach to Objectively Measure Social Engagement in Older Adults With Hearing Loss

An observational study in Hearing Loss, Bilateral (Causes Other Than Tumors), sponsored by University of Southern California. Recruiting at 2 sites in United States. Open to participants aged 60 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-05-11.

Sponsored by University of Southern California · Observational

From the registry’s dates

  • Started Jan 2026; still recruiting 9 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
100
Ages
60 Years and older
Sex
All
01

Study summary

The goal of this clinical trial is to learn if hearing devices, like hearing aids, affect social and cognitive function of older adults. The main questions the researchers want to answer are:

  • How social are older adults with hearing loss before and after using hearing devices?
  • How well do older adults with hearing loss think before and after using hearing devices?
  • For older adults who have hearing loss and use hearing devices, do changes in social interaction explain changes in how well they think (cognitive function)?
  • Do brainwaves (EEGs) in older adults with hearing loss change after using hearing devices?
  • Are there differences in how social older adults with hearing loss are compared to older adults without hearing loss?

What Participants Will Do:

  • Participants will take questionnaires for around 60 minutes. Questionnaires will ask participants about their background, health, hearing, and how social they are. Another set of questionnaires will check their thinking ability or cognition.
  • Participants will wear an audio sensor (TILES Audio Recorder on Jelly Mobile phone) for 2 weeks. The sensor will collect and store information about a participant's voice during conversations. Once the device has information about a participant's voice such as pitch and tone it will store this information and delete the audio recording. Words spoken during conversations will be deleted.
  • (Optional) Participants can choose to participate in a 45-60-minute EEG (electroencephalogram) recording session. Participants will have sensors placed on top of their heads. Sensors will record the participants' brainwaves. Sounds will be played to see how participants' brainwaves change when they hear sounds. Eligible participants will be invited to participate in 4-month follow-up study.
02

Conditions studied

  • Hearing Loss, Bilateral (Causes Other Than Tumors)

Keywords

  • hearing loss
  • hearing aids
  • cognition
  • dementia
03

In context

Hearing Loss

1,092 studies on the registry are indexed under Hearing Loss; 235 are open to participants now.

This study's planned enrollment of 100 is above the median of 87 across 270 observational studies indexed under Hearing Loss.

Browse Hearing Loss studies →

Lead sponsor

University of Southern California is the lead sponsor of 773 studies on the registry; 135 are open to participants now.

Of its 68 completed or terminated interventional studies of FDA-regulated products, 32 (47%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Individuals meeting the inclusion criteria will be recruited from the affiliated tertiary hospitals and hearing aid centers. Both individuals with audiometry-measured bilateral hearing loss who are clinically indicated for hearing aid fitting and healthy volunteers without hearing loss will be recruited to participant in the study.

Inclusion criteria

  • Age >= 60 years
  • English or Spanish speaking
  • Group 1- older adults with normal hearing defined as speech frequency PTA \<25dB HL in bilateral ears
  • Group 2- older adults with bilateral hearing loss who are not using hearing aids
  • Group 3- older adults with bilateral hearing loss, who are currently using hearing aids

Exclusion criteria

Exclusion Criteria:

  • Age \<60 years
  • Unable to complete questionnaires in English or Spanish
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
100 participants (estimated)
Patient registry
No

Groups and cohorts

  • Adults with bilateral hearing loss (hearing aid users)

    Participants with bilateral hearing loss (defined as those with speech-frequency pure-tone average \>=25 dB HL bilaterally) and currently using hearing aids.

    Device: Hearing aid use

  • Adults without hearing loss

    Hearing loss defined as speech-frequency pure-tone average \>=25 dB HL bilaterally

  • Adults with hearing loss (non-hearing aid users)

    Participants with bilateral hearing loss (defined as those with speech-frequency pure-tone average \>=25 dB HL bilaterally) and not currently using hearing aids.

Interventions

  • DeviceHearing aid use

    Hearing aid use will be discussed with all eligible participants with hearing loss and will be encouraged to pursue hearing aid fitting through standard clinical indications via participants' insurance and audiologists.

06

What researchers measure

Primary outcomes

  1. Audio sensor- speech activity

    The audio sensor employs deep-learning-based multimodal speech pattern modeling of participants' own voice activities to extract speech arousal and speech activities. Speech activity measures include the intersession time (the interval between speech sessions, representing the frequency of conversation engagement).

    Time frame: Baseline and 4-month after hearing aid use

  2. Audio sensor- speech arousal

    The audio sensor employs deep-learning-based multimodal speech pattern modeling of participants' own voice activities to extract speech arousal and speech activities. Speech arousal measures include the percentage of strong arousals, serving as a proxy of enhanced engagement in conversations.

    Time frame: Baseline, 4-month after hearing aid use

Secondary outcomes

  1. EEG Measures

    EEG Event Related Potentials (ERPs) are measures of cortical activities in response to auditory stimuli and provide information about cognitive processing, memory, and attention. Participants will complete auditory oddball tasks during EEG measurements and ERPs including P1, N1, P2, MMN, P3 will be recorded.

    Time frame: Baseline, 4-month after hearing aid use

  2. Cognitive test- MoCA

    Montreal Cognitive Assessment (MoCA) The MoCA is a brief cognitive screening tool assessing multiple domains including memory, attention, executive function, language, visuospatial skills, and orientation. The standard MoCA total score ranges from 0 to 30, with higher scores indicating better cognitive function (better outcomes).

    Time frame: Baseline and 4-month after hearing aid use

  3. UCLA Loneliness Scale

    The UCLA Loneliness Scale is a 20-item self-report measure assessing subjective feelings of loneliness and social isolation. Total scores range from 20 to 80, with higher scores indicating greater loneliness and worse outcomes. Minimum score: 20; maximum score: 80. Higher scores represent worse outcomes.

    Time frame: Baseline, optional 4 months follow-up

  4. Lubben Social Network Scale (LSNS-6)

    The Lubben Social Network Scale (LSNS-6) is a 6-item self-report measure assessing social engagement and perceived social support from family and friends. Total scores range from 0 to 30, with higher scores indicating larger and more supportive social networks (better outcomes). Minimum score: 0; maximum score: 30. Higher scores represent better outcomes.

    Time frame: Baseline, optional 4 months follow-up

  5. Duke Social Support Index (DSSI-11)

    The Duke Social Support Index (DSSI-11) is an 11-item self-report measure assessing social support across social interaction and subjective support domains. Total scores range from 10 to 30, with higher scores indicating greater perceived social support (better outcomes). Minimum score: 10; maximum score: 30. Higher scores represent better outcomes.

    Time frame: Baseline, optional 4 months follow-up

  6. Hearing Handicap Inventory for the Elderly - Screening Version (HHIE-S)

    The HHIE-S is a 10-item self-report questionnaire assessing the emotional and social/situational effects of hearing loss in older adults. Total scores range from 0 to 40, with higher scores indicating greater perceived hearing handicap and worse hearing-related quality of life. Minimum score: 0; maximum score: 40. Higher scores represent worse outcomes.

    Time frame: Baseline, optional 4 months follow-up

  7. Generalized Anxiety Disorder 7-item (GAD-7) Scale

    The GAD-7 is a 7-item self-report questionnaire assessing the severity of generalized anxiety symptoms over the past two weeks. Total scores range from 0 to 21, with higher scores indicating greater anxiety severity and worse outcomes. Minimum score: 0; maximum score: 21. Higher scores represent worse outcomes.

    Time frame: Baseline, optional 4 months follow-up

  8. Center for Epidemiologic Studies Depression Scale (CES-D)

    The CES-D is a 20-item self-report questionnaire assessing depressive symptoms in the general population over the past week. Total scores range from 0 to 60, with higher scores indicating greater depressive symptom severity and worse outcomes. Minimum score: 0; maximum score: 60. Higher scores represent worse outcomes.

    Time frame: Baseline, optional 4 months follow-up

  9. Short Form Health Survey - 12 Item (SF-12)

    The SF-12 is a 12-item self-report measure assessing overall health-related quality of life across physical and mental domains. Scores are typically summarized into Physical Component Summary (PCS) and Mental Component Summary (MCS) scores. When reported as a combined or transformed total score ranging from 0 to 200, higher scores indicate better health-related quality of life (better outcomes). Minimum score: 0; maximum score: 200. Higher scores represent better outcomes.

    Time frame: Baseline, optional 4 months follow-up

  10. Short Assessment of Health Literacy (SAHL)

    The SAHL is an 18-item word recognition and comprehension test assessing health literacy. Total scores range from 0 to 18, with higher scores indicating better health literacy (better outcomes). Minimum score: 0; maximum score: 18. Higher scores represent better outcomes.

    Time frame: Baseline, optional 4 months follow-up

07

Study locations

2 of 2 sites recruiting
  • Los Angeles General Medical Center
    Los Angeles, California 90033, United States
    Recruiting
  • University of Southern California
    Los Angeles, California 90066, United States
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 11, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06781749
Lead sponsor
University of Southern California
Responsible party
Janet Choi (Assistant Professor, University of Southern California) — Principal investigator
First posted
Jan 17, 2025
Start date
Jan 1, 2026
Primary completion
Jun 30, 2027 (estimated)
Completion
Jun 30, 2030 (estimated)
Last update
May 11, 2026

Study contacts

Janet Choi, MD, MPH
Contact
janet.choi@med.usc.edu
323-442-5790

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion